P087 Comprehensive evaluation of androgen receptor pathway inhibitor monotherapy in prostate cancer: Safety, oncologic outcomes, and quality of life – a systematic review and meta-analysis

IF 4.5 3区 医学 Q1 UROLOGY & NEPHROLOGY European Urology Open Science Pub Date : 2024-11-01 Epub Date: 2024-11-07 DOI:10.1016/S2666-1683(24)01215-1
Fazekas T., Kói T.S., Miszczyk M., Giesen A., Matsukawa A., Zattoni F., Rodriguez-Sanchez L., Szarvas T., Rivas J.G.M., Nyirády P.T., Shariat S.F., Gandaglia G., Rajwa P.
{"title":"P087 Comprehensive evaluation of androgen receptor pathway inhibitor monotherapy in prostate cancer: Safety, oncologic outcomes, and quality of life – a systematic review and meta-analysis","authors":"Fazekas T., Kói T.S., Miszczyk M., Giesen A., Matsukawa A., Zattoni F., Rodriguez-Sanchez L., Szarvas T., Rivas J.G.M., Nyirády P.T., Shariat S.F., Gandaglia G., Rajwa P.","doi":"10.1016/S2666-1683(24)01215-1","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12254,"journal":{"name":"European Urology Open Science","volume":"69 ","pages":"Pages 105-106"},"PeriodicalIF":4.5000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Urology Open Science","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666168324012151","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/7 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
P087 雄激素受体通路抑制剂单药治疗前列腺癌的综合评估:安全性、肿瘤学结果和生活质量--系统回顾和荟萃分析
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
European Urology Open Science
European Urology Open Science UROLOGY & NEPHROLOGY-
CiteScore
3.40
自引率
4.00%
发文量
1183
审稿时长
49 days
期刊最新文献
Trifecta Outcomes after Robotic Sacrocolpopexy with Dual Mesh in Single-center Cohort Beyond Discrimination Metrics: A Bayesian Reinterpretation of S2,3PSA% for Individual Patient Counseling Treatment Persistence and Adherence with Overactive Bladder Medications in Taiwan: A Retrospective Database Analysis PSA Response as a Prognostic Factor of Overall Survival in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Apalutamide: Real-world Evidence Re: Furrer MA, Lyttwin B, Pärli MS, et al. Incidental Prostate Cancer Is an Uncommon but Clinically Nonnegligible Cause of Death in Selected Long-term Survivors of Urothelial Carcinoma—Oncological Outcomes and a Proposed Follow-up Strategy from a Tertiary Referral Center. Eur Urol Open Sci 2026;86:10–9
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1